Files
Download Full Text (7.8 MB)
Contents
- Sparing Life and Limb
- Can a Common Spice Be Use to Treat Cancer?
- House Call: Your First Colonoscopy: Here's What You Can Expect
- DiaLog: Targeted Therapies Are Here to Stay, by Gabriel N. Hortobagyi, MD
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
2007
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Cannon, Christopher; Lewis, Valerae; Cortes, Jorge; Kurzrock, Razelle; Aggarwal, Bharat B., 1950-; Lu, Charles; Bresalier, R.S. (Robert S.); Varadhachary, Gauri; Roth Jack A.; Beach, Jenny; Jenkins, Jan; Osteosarcoma; Limb Salvage; Sarcoma, Ewing; Prostheses and Implants; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Cytogenetics; Curcumin; Clinical Trials as Topic; NF-kappa B; Neoplasms; Neoplasms, Unknown Primary; Carcinoma, Non-Small-Cell Lung; TUSC2 protein, human; Tumor Suppressor Proteins; 1,2-dioleoyloxy-3-(trimethylammonium)propane; Cholesterol; Nanoparticles; Colonoscopy; Polyps; Molecular Targeted Therapy; Interferon alpha-2; Survival Rate.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Hosemann, Sunni; Witter, Diane; and Hortobagyi, Gabriel N. MD, "OncoLog, Volume 52, Number 09, September 2007" (2007). OncoLog MD Anderson's Report to Physicians (All issues). 168.
https://openworks.mdanderson.org/oncolog/168
Conditions Governing Access
Open
